Kymera Therapeutics Inc (KYMR) Company Profile & Statistics

Kymera Therapeutics Inc
KYMR
(Nasdaq - US)
N/A
38.42
-0.02 (-0.05%)
in:usd•As of: May 08, 2024 11:51 UTC -4
Open
37.99
High
38.64
Low
37.67

About Kymera Therapeutics Inc

CEO

Nello Mainolfi

Headquarters

200 arsenal yards blvd., suite 230

watertown, ma 02472, united states

Auditor

Ernst & Young LLP

Employees

187

Share Holders

Website

www.kymeratx.com

Industry

biotechnology

Sector

health technology

Company Overview

Kymera Therapeutics Inc. is a biopharmaceutical company. It is focused on discovering and developing small molecule therapeutics for degrade dysregulated, disease-causing proteins to address previously intractable disease targets. Kymera Therapeutics Inc. is based in Watertown, United States.

Kymera Therapeutics Inc Statistics

Valuation Measures

Market Capitalization ²	2.36B
Enterprise Value	2.25B
Enterprise Value/EBITDA (ttm)	-13.46
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	3.30
Price to Sales (ttm)	29.59
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	100.00%
Operating Margin (ttm)	-194.67%
Profit Margin (ttm)	-453.88%
Return on Equity (ttm)	-31.92%
Return on Invested Capital (ttm)	-34.70%
Return on Assets (ttm)	-23.98%

Income Statement

Revenue (ttm)	78.59M
Revenue Per Share (ttm)	1.29
Gross Profit (ttm)	78.59M
EBITDA (ttm)³	-167.19M
Net Income Avi to Common (ttm)	-146.96M
Diluted EPS (ttm)	-2.51

Share Statistics

Beta (5Y Monthly)	2.31
52-Week Change	38.50%
S&P500 52-Week Change	27.81%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	61.11M
Dividend Yield	0.00%
Float ⁴	51.65M
% Held by Insiders	15.82%
% Held by Institutions	N/A

Balance Sheet

Total Cash (mrq)	374.88M
Total Cash Per Share (mrq)	6.13
Total Debt (mrq)	2.58M
Total Debt/Equity (mrq)	0.65%
Current Ratio (mrq)	4.73%
Quick Ratio (mrq)	9.57%
Book Value Per Share (mrq)	7.11

Cash Flow

Operating Cash Flow Per Share (ytd)	-1.76
Free Cash Flow (ytd)	-137.31M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Kymera Therapeutics Inc

Trade With A Regulated Broker